-
When Digital Payment Goes Viral: Lessons from COVID-19’s Impact on Mobile Money in Rwanda
Cash can help spread COVID-19, so some African countries have ramped up efforts to expand digital payments to fight the virus. According to Isabelle Carboni and Hennie Bester at Cenfri, this imperative to digitize is one of the key opportunities to emerge from the pandemic. They explore the early experiences of Rwanda, in assessing the impact these efforts can have.
- Categories
- Coronavirus, Finance
-
GIIN Launches Impact Investing Coronavirus Taskforce
Impact investing giants from across the globe are joining forces to fight the devastating and widespread economic and social consequences of COVID-19.
- Categories
- Investing
-
Impact Measurement and Management During COVID-19: Tips and Resources to Help Social Impact Organizations Adapt
As the scope of the COVID-19 economic crisis becomes clear, social impact organizations are scrambling to cut costs. According to Matthew Guttentag and Mallory St. Claire at ANDE, this might lead them to reduce their focus on impact measurement and management (IMM). They explain why this would be a mistake – and how organizations can adapt their IMM activities during the crisis.
- Categories
- Coronavirus, Impact Assessment
-
Study Examines India’s Policies for Financial Inclusion of the Unbanked
With about 190 million unbanked adults, India is second only to China among developing countries in the number of residents who don't have bank accounts or participate in the formal financial sector, according to World Bank.
- Categories
- Finance
- Region
- South Asia
-
Data Around COVID-19 Is a Mess and Here’s Why That Matters
Aid organizations use data to help understand needs and target their interventions – but their analyses and responses are only as good as the data at hand.
- Categories
- Coronavirus
-
In Philanthropy, Race Is Still a Factor in Who Gets What, Study Finds
The data is being released to show the philanthropic community how entrenched and persistent unequal funding is, said Cheryl L. Dorsey, president of Echoing Green
-
Big Pharma’s Blindspot: Before COVID-19, Vaccine and Antiviral Research Went Neglected
Public health experts have warned for years that the world is at risk of a major pandemic, and advocates say Big Pharma showed little interest in developing vaccines — or even antibiotic and antiviral medications — until the latest outbreak offered an opportunity to rake in public funding and turn out massive profits with minimal risk.
- Categories
- Coronavirus, Health Care
-
Responding to COVID-19 in the Developing World
The mass social distancing strategy being used to mitigate the spread of COVID-19 in the United States and Europe doesn’t easily translate to a developing country like Bangladesh, which lacks the capacity to impose restrictions or provide a social safety net for the unemployed. We talked with Yale SOM development economist Mushfiq Mobarak about how he is repurposing his research infrastructure in Bangladesh to gather information and test approaches to spreading public health messages.
- Categories
- Coronavirus
- Region
- South Asia
Parent Organization
